Concomitant medical products: product id: 37601, serial# (b)(4), implanted: (b)(6) 2015, product type: implantable neurostimulator.Product id: 64002, lot# n494166, implanted: (b)(6) 2015, product type: adapter.Product id: 7482a51, serial# (b)(4), implanted: (b)(6) 2010, product type: extension.Product id: 3387s-40, lot# v487953, implanted: (b)(6) 2010, product type: lead.Product id: 3387s-40, lot# v511640, implanted: (b)(6) 2010, product type: lead.(b)(4).
|
Information was received from the company representative that reported the deep brain stimulator (dbs) leads were in the right place but when he turned his stimulation on he had more pain and was unable to walk and couldn't speak but his tremors were controlled.They were never told about the dbs side effects.The patient believed it was the dbs that put him in a wheelchair.These issues were from the time of implant.It was a sudden change in therapy/symptoms.The patient was implanted for dystonia.Additional information received 6 days later reported the patient was seen in recovery following a battery replacement and was still feeling the effects of anesthesia.He previously had a primary cell device and now with the new implantable neurostimulator (ins) patient programmer (pp) the patient thought he would be able to better titrate his stimulation per his neurologist.The only option the patient wanted to take in post-operation was to set his stimulation at a lower level or to turn his stimulation off.They were instructed how to do so using the programmer.The patient needed to rest after surgery so the company representative wasn't able to do any troubleshooting.The patient was going to follow-up with their neurologist to further troubleshoot/diagnose issues related to pain, speaking, and walking.Further follow-up was being conducted to determine what troubleshooting/diagnostics were done to address the patient's symptoms.If additional information is received, a follow-up report will be submitted.
|